🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Chuck Royce’s HNGE Holdings & Trades

First Buy
Q4 2025
Duration Held
3 Quarters
Largest Add
Q1 2026
+52,010 Shares
Current Position
123,530 Shares
$10.25 M Value

Chuck Royce's HNGE Position Overview

Chuck Royce (via Royce & Associates Lp) currently holds 123,530 shares of Hinge Health, Inc. (HNGE) worth $10.25 M, representing 0.08% of the portfolio. First purchased in 2025-Q4, this short-term holding has been held for 3 quarters.

Based on 13F filings, Chuck Royce has maintained this position in HNGE for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 52,010 shares.

Analysis based on 13F filings available since 2013 Q2

Chuck Royce's Hinge Health (HNGE) Holding Value Over Time

Track share changes against reported price movement

Quarterly Hinge Health (HNGE) Trades by Chuck Royce

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q2 2026 +26,509 Add 27.32% 123,530 $83.00
Q1 2026 +52,010 Add 115.55% 97,021 $38.56
Q4 2025 +45,011 New Buy 45,011 $46.45

Chuck Royce's Hinge Health Investment FAQs

Chuck Royce first purchased Hinge Health, Inc. (HNGE) in Q4 2025, acquiring 45,011 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Chuck Royce has held Hinge Health, Inc. (HNGE) for 3 quarters since Q4 2025.

Chuck Royce's largest addition to Hinge Health, Inc. (HNGE) was in Q1 2026, adding 97,021 shares worth $3.74 M.

According to the latest 13F filing for Q2 2026, Chuck Royce's firm, Royce & Associates Lp, owns 123,530 shares of Hinge Health, Inc. (HNGE), valued at approximately $10.25 M.

As of the Q2 2026 filing, Hinge Health, Inc. (HNGE) represents approximately 0.08% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.

Chuck Royce's peak holding in Hinge Health, Inc. (HNGE) was 123,530 shares, as reported at the end of Q2 2026.